You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer
- 2. Janux Therapeutics Announces $56 Million Series A to Advance Novel Cancer Drug Candidates Using T Cell Engager (TRACTr) Technology
- 3. Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
- 4. Cell Therapy Company Raises $160 Million to Advance iPSC-Derived Therapies to Clinic
- 5. Money on the Move: February 24 – March 2
- 6. Top 10 Pharm Country Companies to Receive NIH Funding in 2020
- 7. Biotheus Completes $100 Million Funding for Biologic Drugs
- 8. Xentria Announces Submission of an Investigational New Drug (IND) Application for XTMAB-16 in the Treatment of Sarcoidosis
- 9. Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals
- 10. A need for experts in pediatric onco-nephrology
Last updated at 21:08 GMT
Hot News Makers
Health/Pharma Companies
-
101192.81
-
82849.96
-
63516.17
-
47426.22
-
36814.54
-
27905.38
-
24384.91
-
23462.24
-
17069.50
-
16044.45
Last updated at 21:10 GMT
© Copyright 2021 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK